Research projects

​​A cross-sectional study describing the prevalence of diabetic neuropathy based on questionnaire data and objective measures and their association to prevalent diabetic complications including The duration of inclusion of participants in the study is estimated to be 3 years.

​​Deep phenotyping of the heart with advanced imaging modalities in type 2 diabetes – implications for pathophysiology and prognosis.

​PERLage is the follow up study of PERL which were a randomized doubled blind placebo controlled trial with a 3 year treatment of allopurinol/placebo to investigate whether allopurinol slows early function decline in persons with type 1 diabetes and early diabetic kidney disease.

​​Prevalence and progression of subclinical cardiovascular disease assessed by 3D ultrasound of the carotid arteries and relation to platelet aggregation in individuals with type 2 diabetes.

​PRIORITY: Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In Type 2 diabetic patients with normoalbuminuria.

​​Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation – A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetes.

​A Study to Assess the Effects of the Endothelin Receptor Antagonist Zibotentan and the SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes and elevated Albuminuria​.